Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
Perhaps worth bearing in mind that in the year to july, hotel chocolat recorded a loss of £800m, so obviously other factors apart from pure profitability came into play.
Interesting to read the terms of the ocado RNS, as to the timescale of the deal, financial impact and revenue recognition etc .worth a look.
And from what source? don't hold your breath for a sensible informative reply!
Exactly,81.even if the intention to take up the extension option was in the pipeline a while ago,it will still have had to be sanctioned by the new owners,so a double level of approval in effect.
Eroxon, not fortacin! sorry.
Interesting find,DRM.encouraging that M8 has expanded its involvement with fortacin so soon after its acquisition by Acino.
Yes,excellent RNS.clearly indicates MS are very happy with the developments so far and see the potential in further expansion in their specialist geographical area. we are starting to get a strong sense of how the truly global expansion is developing. very pleased!
Morning bignose. a sobering thought,indeed. sadly i can't really disagree with anything you have said. perhaps im just a slightly more optimistic person by nature (should that read "naive"?),but i haven't completely given up on the FDA, but i have to accept that all the evidence to date points to your conclusion. as always,time will tell.
Im inclined to agree that we may well see us interest rate cuts earlier than expected.suspect they may have overshot on the raising side.time will tell.
Im still here keith. has'nt really been anything to say, as radio silence continues. we can draw differing inferences from the silence,depending on our individual attitudes to the company and whether we are optimistic or pessimistic by nature. my view is that if they had anything positive to report they would do so,but who knows. i can't offer any words of comfort,but im still invested for what that is worth.
Excellent news. great endorsement, which i imagine fum/coopers will be able to use to great advantage in the advertising/publicity area.
It's from the corporate update RNS on the 30th oct. it does say"detracted"
Obviously you can,as otherwise you wouldn't have been able to.not sure that that is a cogent reason for doing so,but i accept that these exchanges are vapid and pointless. quite pleased to be described as a "square". though. that's an accolade in my book!
Cong ,why do you post this drivel !it is intellectually demeaning! just my opinion of course
On that score frankmu, the terms and rapidity of a new china deal may be instructive.potential licensees will no doubt have the benefit of at least some preliminary data re sales and in particular feedback and repeat orders. if the terms are good and a deal is completed pretty quickly this would be a good indication (imo) of how its efficacy is perceived by users.
Also,the deal with cohigh/riverwood was completed before the EU approval (and before the firm indication that it was going to be approved), so arguably fum are in a much stronger position,with FDA approval also in the bag, than when that was completed. hopefully better terms this time.
With respect D&D, i think you are expecting too much too soon it doesn't appear that coopers operate in all the eu countries. from their website it looks as though we have supplies in all. or almost all, the ones mentioned.i assume we can expect other partners to materialise at some point where appropriate for other areas.aimo https://www.cooperconsumerhealth.eu/our-global-presence/
It's online in italy ,france and spain.
Perhaps i'm missing the point, but i'm not sure why a downgrade of the council's creditworthiness should be viewed as bad news for THG/moulding.
So would i.all the usual and necessary disclaimers and cautions were given.